Gemcitabine and Docetaxel for Hepatocellular Carcinoma: A Phase II North Central Cancer Treatment Group Clinical Trial : American Journal of Clinical Oncology

Secondary Logo

Journal Logo

Original Articles: Gastrointestinal

Gemcitabine and Docetaxel for Hepatocellular Carcinoma

A Phase II North Central Cancer Treatment Group Clinical Trial

Alberts, Steven R. MD, MPH*; Reid, Joel M. PhD*; Morlan, Bruce W. MS*; Farr, Gist H. Jr MD; Camoriano, John K. MD; Johnson, David B. MD§; Enger, James R. MD; Seay, Thomas E. MD; Kim, George P. MD

Author Information
American Journal of Clinical Oncology 35(5):p 418-423, October 2012. | DOI: 10.1097/COC.0b013e318219863b

Abstract

© 2012 Lippincott Williams & Wilkins, Inc.

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid